Viewing Study NCT00236210



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00236210
Status: COMPLETED
Last Update Posted: 2009-08-04
First Post: 2005-10-07

Brief Title: A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program
Sponsor: Group Health Centre
Organization: Group Health Centre

Study Overview

Official Title: The Vascular Intervention Project VIP a Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program in the Algoma District of Northern Ontario
Status: COMPLETED
Status Verified Date: 2009-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: VIP is a demonstration project with a goal to decrease modifiable risk factors for those with a higher risk of having a vascular event such as a heart attack or stroke or of developing vascular disease Introduced as a study VIP compares whether there is a significant reduction of modifiable vascular risk factors among patients who are involved in a personalized directed program versus those being provided standard care by their physician Health care providers work collaboratively with the VIP Team to improve the participants vascular health
Detailed Description: This Northern Ontario community-based demonstration project is a multi-disciplinary primary care provider-based collaboration The goals of the project are to

1 Decrease the modifiable risk factors for primary care patients at risk for vascular disease in the Algoma District
2 Increase collaboration between health care providers such as family physicians pharmacists physiotherapists dietitians and nurses in the community
3 Increase the participation of the patient and family in decision-making self-care and adherence to agreed-upon management plans
4 Improve patient access to care clinical outcomes and satisfaction
5 Provide a business case for a practical sustainable and generalizable model for the primary care of vascular disease in the community

The Group Health Centre a multi-disciplinary not-for-profit community-based health organization with 56000 rostered patients leads the project However all Sault Ste Marie community patients are eligible to join the Vascular Intervention Program VIP This program has three key components a registry of VIP patients with audit recall and feedback use of the novel ACTION score template and the optional use of VIPNet a personalized patient record tool that provides secure web access to optimize quality and continuity of care The VIP project aims to empower patients and increase collaboration among the primary health care team Patients with any vascular risk factors will be eligible for VIP

The VIP project is a demonstration project that does not duplicate existing GHC chronic disease management programs because 1 the VIP is offered to all eligible community patients not only GHC enrollees 2 VIP integrates any patients with vascular risk not just those with pre-defined conditions 3 novel collaborative tools such as the ACTION template and VIPNet website are being piloted and 4 explicit patient-centred decision making drives the process The development and evaluation of the VIP demonstration project is a unique step in the evolution of primary care chronic disease management in Sault Ste Marie and the rest of the province

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None